Arcturus Therapeutics Holdings Inc. (ARCT) Earnings Call Transcript & Summary

November 10, 2020

NASDAQ US Health Care Biotechnology shareholder_meeting 8 min

Earnings Call Speaker Segments

Joseph Payne

executive
#1

Good morning, and welcome to a special meeting of stockholders of Arcturus Therapeutics Holdings, Inc. Due to the ongoing COVID-19 pandemic, we are holding this special meeting as an entirely virtual meeting. Stockholders who require technical assistance during the meeting can call Continental's technical support line at the phone number posted on the meeting login page. I am Joe Payne, the President and CEO as well as a member of the Board of Directors. It's now 9:00 a.m. Pacific Time on November 10, 2020, and this meeting will please come to order. Also participating in this meeting; Dr. Pad Chivukula, our Chief Scientific Officer and Chief Operating Officer of the company; Mr. Jeffrey Baumel of Dentons US LLP, our counsel to the company; and Mr. Isaac Kagan of Continental Stock Transfer & Trust Company, who has been appointed as inspector of election for the meeting. Members of our Board of Directors are also participating in this virtual meeting. I would now like to proceed with the formal business of the meeting. I will act as Chairperson of the meeting, and Dr. Pad Chivukula will act as Secretary of the meeting. The matter on which the stockholders at today's meeting are voting is in the amendment of our certificate of incorporation. To increase the number of shares of common stock, we are authorized to issue from 30 million shares to 60 million shares. I turn the time to you, Isaac.

Isaac Kagan

attendee
#2

I present a list of Arcturus' stockholders as of the close of business on September 18, 2020, which is the record date for this meeting. The stockholders on this list are entitled to vote at this meeting. This list has been certified by Continental Stock Transfer & Trust Company, the transfer agent for the company's common stock.

Joseph Payne

executive
#3

The list of stockholders is open for inspection by any stockholder participating in this meeting and can be examined during this meeting by calling Dentons at (212) 632-5556. Our Continental Stock Transfer & Trust Company has also certified that each stockholder entitled to vote at this meeting has been sent a notice of this meeting accompanied by the proxy statement. The initial order of business is to determine the presence of a quorum. Pursuant to action taken by the Board of Directors, only stockholders of record or common stock as of September 18, 2020, are entitled to notice of and to vote at this special meeting. Mr. Isaac Kagan has been appointed as inspector of election and has executed the required Oath. Isaac?

Isaac Kagan

attendee
#4

Mr. Chairman, I wish to report that I have examined the list of stockholders entitled to vote at this meeting. And have determined that the number of shares of outstanding common stock at the record date is 24,473,002. Holders of at least 33.33% percent of the voting power of the company's outstanding common stock entitled to vote at this meeting must be present in person or represented by proxy for us to hold and transact business at this meeting. On the record date, there were 24,473,002 shares outstanding and entitled to vote. Thus, the holders of at least 8,157,668 shares must be present in person or represented by proxy at this meeting to have a quorum. The number of votes represented at this meeting in person or by proxy is 21,118,690, which constitutes 86% of the total outstanding shares of the common stock.

Joseph Payne

executive
#5

I hereby determine that the number of votes represented at this meeting in person or by proxy constitutes a quorum for the conduct of business at this meeting. The matter to be voted on today is the amendment of our certificate of incorporation to increase the number of shares of common stock we are authorized to issue from 30 million shares to 60 million shares. As set forth more fully in Proposal #1 of the proxy statement. A motion to approve Proposal #1 is now in order.

Isaac Kagan

attendee
#6

I hereby move to approve Proposal #1.

Joseph Payne

executive
#7

And I second the motion, and hereby declare this motion do we made. It is now ordered that the polls be opened for voting on Proposal #1 as described more fully in the proxy statement. Any stockholder who has not yet voted or wishes to change their vote, may do so by clicking on the voting button on the web portal. And following the instructions there. Stockholders who have sent in proxies or voted via Internet and do not want to change their vote do not need to take any further action. We will be declaring the polls closed in 1 minute. [Voting]

Joseph Payne

executive
#8

All right. The votes are in, and I declare the polls closed. The inspector will now report on the votes properly made prior to the meeting. The inspector will provide the company with a final report tomorrow that reflects any votes properly made at this meeting.

Isaac Kagan

attendee
#9

As given in the proxy statement...

Joseph Payne

executive
#10

Go ahead, Isaac. Yes.

Isaac Kagan

attendee
#11

As given in the proxy statement, the amendment of the company's certificate of incorporation to increase the number of shares of common stock is authorized to issue from 30 million shares to 60 million shares requires the approval of a majority of the capital stock entitled to vote. As 79% of shares entitled to vote have approved this proposal, I hereby declare that the Proposal #1 has been approved on a preliminary basis.

Joseph Payne

executive
#12

Thank you, Mr. Kagan. You have heard the preliminary report of the inspector, and I declare that Proposal #1 has passed on a preliminary basis and has been duly approved by the stockholders of the company on a preliminary basis. I hereby request that the preliminary report of the inspector be filed within -- with the minutes of this meeting. The final report of the inspector will be provided to the company by Tuesday, November 17. This completes the stockholder voting to be conducted at this meeting. And since there's no other matters to come before this meeting, a motion to adjourn the meeting is now in order.

Isaac Kagan

attendee
#13

I move the meeting be adjourned.

Joseph Payne

executive
#14

I -- And the motion has been carried. And the meeting is adjourned. Thank you, everyone.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Arcturus Therapeutics Holdings Inc. transcript — plus 252,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Arcturus Therapeutics Holdings Inc. earnings transcripts and 252,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.